Biocept (BIOC) Reports Q4 Loss of $0.24
Tweet
Share
E-mailGet Alerts BIOC Hot Sheet
Join SI Premium – FREE
Biocept (NASDAQ: BIOC) reported Q4 EPS of ($0.24), versus ($0.87) reported last year. Revenue for the quarter came in at $218 million, versus $76 million reported last year.
For earnings history and earnings-related data on Biocept (BIOC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan is worried about further S&P 500 sell-off potential
- Novartis (NVS) Tops Q1 EPS by 13c, raises guidance
- Cleveland-Cliffs Q1 results miss estimates on hit from buyers strike
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
